A phase I/II clinical trial of the reversible LSD1 inhibitor, seclidemstat, in patients with relapsed/refractory Ewing sarcoma Meeting Abstract
| Authors: | Reed, D. R.; Mascarenhas, L.; Meyers, P. A.; Chawla, S. P.; Harrison, D. J.; Setty, B.; Metts, J.; Wages, D. S.; Stenehjem, D. D.; Santiesteban, D. Y.; DuBois, S. G. |
| Abstract Title: | A phase I/II clinical trial of the reversible LSD1 inhibitor, seclidemstat, in patients with relapsed/refractory Ewing sarcoma |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368309033 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.TPS11567 |
| Notes: | Meeting Abstract: TPS11567 -- Source: Wos |
